Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cell-based passive immunization for protection against SARS-CoV-2 infection.
Sawula E, Miersch S, Jong ED, Li C, Chou FY, Tang JK, Saberianfar R, Harding J, Sidhu SS, Nagy A. Sawula E, et al. Among authors: saberianfar r. Stem Cell Res Ther. 2023 Nov 6;14(1):318. doi: 10.1186/s13287-023-03556-5. Stem Cell Res Ther. 2023. PMID: 37932852 Free PMC article.
Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape Mutations.
Miersch S, Li Z, Saberianfar R, Ustav M, Brett Case J, Blazer L, Chen C, Ye W, Pavlenco A, Gorelik M, Garcia Perez J, Subramania S, Singh S, Ploder L, Ganaie S, Chen RE, Leung DW, Pandolfi PP, Novelli G, Matusali G, Colavita F, Capobianchi MR, Jain S, Gupta JB, Amarasinghe GK, Diamond MS, Rini J, Sidhu SS. Miersch S, et al. Among authors: saberianfar r. J Mol Biol. 2021 Sep 17;433(19):167177. doi: 10.1016/j.jmb.2021.167177. Epub 2021 Jul 28. J Mol Biol. 2021. PMID: 34329642 Free PMC article.
Peptide-Antibody Fusions Engineered by Phage Display Exhibit an Ultrapotent and Broad Neutralization of SARS-CoV-2 Variants.
Labriola JM, Miersch S, Chen G, Chen C, Pavlenco A, Saberianfar R, Caccuri F, Zani A, Sharma N, Feng A, Leung DW, Caruso A, Novelli G, Amarasinghe GK, Sidhu SS. Labriola JM, et al. Among authors: saberianfar r. ACS Chem Biol. 2022 Jul 15;17(7):1978-1988. doi: 10.1021/acschembio.2c00411. Epub 2022 Jun 22. ACS Chem Biol. 2022. PMID: 35731947
Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.
Suryamohan K, Diwanji D, Stawiski EW, Gupta R, Miersch S, Liu J, Chen C, Jiang YP, Fellouse FA, Sathirapongsasuti JF, Albers PK, Deepak T, Saberianfar R, Ratan A, Washburn G, Mis M, Santhosh D, Somasekar S, Hiranjith GH, Vargas D, Mohan S, Phalke S, Kuriakose B, Antony A, Ustav M Jr, Schuster SC, Sidhu S, Junutula JR, Jura N, Seshagiri S. Suryamohan K, et al. Among authors: saberianfar r. Commun Biol. 2021 Apr 12;4(1):475. doi: 10.1038/s42003-021-02030-3. Commun Biol. 2021. PMID: 33846513 Free PMC article.
Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape Mutations.
Miersch S, Li Z, Saberianfar R, Ustav M, Case JB, Blazer L, Chen C, Ye W, Pavlenco A, Gorelik M, Perez JG, Subramania S, Singh S, Ploder L, Ganaie S, Chen RE, Leung DW, Pandolfi PP, Novelli G, Matusali G, Colavita F, Capobianchi MR, Jain S, Gupta JB, Amarasinghe GK, Diamond MS, Rini J, Sidhu SS. Miersch S, et al. Among authors: saberianfar r. bioRxiv [Preprint]. 2020 Dec 21:2020.10.31.362848. doi: 10.1101/2020.10.31.362848. bioRxiv. 2020. PMID: 33398270 Free PMC article. Updated. Preprint.
17 results